<DOC>
	<DOC>NCT02788617</DOC>
	<brief_summary>This prospective study will evaluate the efficacy of Diafert as an adjunct to morphological assessment in predicting embryos' potential to develop to the blastocyst stage on Day 5.</brief_summary>
	<brief_title>Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Provide written informed consent before initiation of any study procedures Be a female outpatient, â‰¥ 18 years of age at the time of informed consent Have at minimum 10 mature egg follicles as of the last transvaginal ultrasound following hormonal stimulation Eligible to allow embryos to develop through day 5 before implantation or freezing Presence of ovarian endometriotic cyst Presence or history of diagnosed severe endometriosis (i.e. stage IV the revised American Fertility Society classification for endometriosis). Need for preimplantation genetic diagnosis/screening of embryos Use of timelapse embryo imaging Employee or immediate relative of an employee of Forest Research Institute, Inc., any of its affiliates or partners, or the study center</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>